• Lysoptosis: An Evolutionarily Conserved Cell Death Pathway

  2026-07-14

  The referenced study characterizes lysoptosis as a distinct, evolutionarily conserved form of lysosome-dependent cell death (LDCD), regulated by intracellular serpins. Using cross-species models, the authors delineate lysoptosis from other cell death pathways and highlight its relevance for understanding regulated cell death in mammalian systems. These insights have practical implications for researchers studying apoptosis, cell death modulation, and therapeutic targeting of protease inhibitors.

• Streptavidin-Cy3: High-Affinity Fluorescent Biotin Detection

  2026-07-14

  Streptavidin-Cy3 is a robust biotin detection reagent offering high-affinity, irreversible binding and bright fluorescence for sensitive biotinylated molecule detection. The streptavidin cy3 conjugate is validated for use in immunohistochemistry and flow cytometry, with protocol parameters optimized for stability and reproducibility.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Surfac

  2026-07-13

  Sulfo-NHS-Biotin offers unmatched selectivity for cell surface protein labeling, streamlining workflows that demand high-fidelity biotinylation in aqueous environments. Its water solubility and amine reactivity make it ideal for affinity chromatography, immunoprecipitation, and advanced single-cell assays—enabling scalable, reproducible research outcomes.

• Spermine: Endogenous Polyamine for Ion Channel Innovation

  2026-07-13

  Spermine is transforming ion channel research by enabling precise modulation of inward rectifier potassium channels and advancing membrane fusion studies. This article details optimized workflows, troubleshooting guidance, and cross-domain applications that set APExBIO’s high-purity Spermine apart for robust, reproducible results.

• Aztreonam in Research: Applied Workflows for Gram-Negative S

  2026-07-12

  Aztreonam’s unique monocyclic β-lactam structure empowers precise studies of Gram-negative resistance, bone marrow toxicity, and hepatic metabolism. This guide translates bench research into actionable workflows and troubleshooting tips for maximizing experimental reproducibility and insight.

• U 46619 in Cardiovascular Research: Precision Modeling Beyon

  2026-07-10

  Explore the multifaceted applications of U 46619 (11,9 epoxymethano-prostaglandin H2) in advanced cardiovascular and renal research. This article reveals nuanced mechanistic insights and protocol optimizations, distinguishing itself from existing resources.

• Acetylspiramycin Workflows: Advancing Antimicrobial Resistan

  2026-07-09

  Acetylspiramycin (Spiramycin B) offers distinct advantages over traditional macrolides for studying antimicrobial resistance and immune modulation in bacterial infection. Its potent activity against macrolide-resistant Mycoplasma pneumoniae, combined with robust solubility and immune effects, positions it as a versatile tool for both susceptibility testing and host-pathogen assays.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-07-09

  This study demonstrates that cannabidiol (CBD) robustly alleviates both sensory and emotional components of orofacial inflammatory pain in mice by targeting coordinated endocannabinoid and serotonergic mechanisms. The findings provide evidence for CBD’s multidimensional analgesic potential and inform future translational research on pain and affective comorbidities.

• Erlotinib (NSC 718781): Precision Tools for EGFR Signaling A

  2026-07-08

  Explore how Erlotinib (NSC 718781) empowers advanced cancer research through highly selective EGFR signaling pathway inhibition. This article uniquely guides assay design and mechanistic studies, integrating breakthrough insights on SCUBE3’s role in oncogenic resistance.

• K+ Channel Blockade and Renal Blood Flow in Septic Rats

  2026-07-08

  This study demonstrates that blocking ATP-sensitive and calcium-activated potassium channels in septic rat models can exacerbate reductions in renal blood flow, especially when combined with vasopressor agents. The findings underscore the complex regulatory role of K+ channels in renal hemodynamics during sepsis and inform mechanistic research on vascular dysfunction.

• PSPro Enables Spatial Proteome Profiling at Single-Cell Type

  2026-07-07

  The PSPro method, as reported by Mao et al., introduces a proximity labeling-based approach for spatial proteomics, achieving single-cell-type resolution in complex tissue slices. By optimizing antibody-guided biotinylation and affinity purification, PSPro reveals spatial heterogeneity across multiple cell types, providing a substantial advance for tissue-based molecular profiling.

• I-BET-762: BET Inhibitor Protocols for Ferroptosis and Infla

  2026-07-07

  I-BET-762, a selective BET inhibitor, empowers precise control of ferroptosis and inflammatory gene regulation in diverse preclinical models. This guide translates the latest mechanistic findings into actionable workflows and troubleshooting strategies, highlighting APExBIO's compound as an essential tool for cutting-edge epigenetic and cancer research.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery

  2026-07-06

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome lipid for siRNA and mRNA delivery. It enables endosomal escape, with documented 1000-fold higher potency for hepatic gene silencing versus predecessors. Its role in advanced lipid nanoparticle (LNP) design is essential for therapeutic and research workflows.

• Strategic c-Myc-Max Inhibition: From Mechanism to Translatio

  2026-07-06

  This thought-leadership article delivers a mechanistic and strategic roadmap for translational researchers seeking to leverage c-Myc-Max dimerization inhibition—focusing on 10058-F4—as both an investigative and workflow-optimizing tool in oncology and stem cell research. Integrating recent advances in telomerase regulation, DNA repair, and apoptosis, the article contextualizes 10058-F4’s unique value proposition versus conventional inhibitors, providing actionable protocol guidance, competitive insights, and an evidence-driven outlook for the next generation of translational studies.

• Vernakalant Hydrochloride: Precision Ion Channel Blockade in

  2026-07-05

  Explore Vernakalant Hydrochloride’s atrial-selective ion channel mechanism, clinical protocol design, and translational assay implications. This in-depth analysis highlights unique PK/PD insights and practical guidance for advanced atrial fibrillation research.

16486 records 1/1100 page Next 12345 下5页 Last page